Inhibition of Fatty Acid Oxidation as a New Target To Treat Primary Amoebic Meningoencephalitis.
Naegleria fowleri
Naegleria gruberi
drug targets
energy metabolism
lipid metabolism
therapy
thioridazine
treatment
Journal
Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061
Informations de publication
Date de publication:
22 07 2020
22 07 2020
Historique:
received:
26
02
2020
accepted:
03
06
2020
pubmed:
10
6
2020
medline:
22
6
2021
entrez:
10
6
2020
Statut:
epublish
Résumé
Primary amoebic meningoencephalitis (PAM) is a rapidly fatal infection caused by the free-living amoeba
Identifiants
pubmed: 32513800
pii: AAC.00344-20
doi: 10.1128/AAC.00344-20
pmc: PMC7526813
pii:
doi:
Substances chimiques
Fatty Acids
0
Amphotericin B
7XU7A7DROE
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2020 Sarink et al.
Références
Antimicrob Agents Chemother. 2008 Nov;52(11):4010-6
pubmed: 18765686
Sci Rep. 2018 Aug 20;8(1):12471
pubmed: 30127400
Antimicrob Agents Chemother. 2015 Nov;59(11):6677-81
pubmed: 26259797
PLoS Negl Trop Dis. 2019 Feb 11;13(2):e0007173
pubmed: 30742620
Antimicrob Agents Chemother. 2019 Dec 20;64(1):
pubmed: 31685474
Antimicrob Agents Chemother. 2012 Nov;56(11):5450-7
pubmed: 22869574
Emerg Infect Dis. 2011 Feb;17(2):258-61
pubmed: 21291600
Acta Trop. 2016 Dec;164:375-394
pubmed: 27616699
Curr Drug Discov Technol. 2018;15(3):201-213
pubmed: 28748751
PLoS One. 2018 Aug 8;13(8):e0201767
pubmed: 30089175
Pediatr Neurol. 2017 May;70:75-79
pubmed: 28389055
FEBS Lett. 1985 Aug 5;187(2):331-3
pubmed: 4018269
Cell. 2010 Mar 5;140(5):631-42
pubmed: 20211133
Trends Parasitol. 2020 Jan;36(1):19-28
pubmed: 31744676
BMC Genomics. 2014 Jun 19;15:496
pubmed: 24950717
Nat Rev Drug Discov. 2004 Jun;3(6):509-20
pubmed: 15173840
Nat Rev Drug Discov. 2019 Jan;18(1):41-58
pubmed: 30310233
J Biol Chem. 1994 Oct 21;269(42):26443-8
pubmed: 7929365
J Antimicrob Chemother. 2012 Nov;67(11):2576-97
pubmed: 22833634
J Antimicrob Chemother. 2006 Jun;57(6):1153-60
pubmed: 16627591
Antimicrob Agents Chemother. 2010 Feb;54(2):602-9
pubmed: 19995928
J Parasitol. 2000 Feb;86(1):50-5
pubmed: 10701563
Biochem Pharmacol. 1996 Jul 26;52(2):273-80
pubmed: 8694852
Psychiatry Res. 1988 Jan;23(1):1-10
pubmed: 3363012
Curr Infect Dis Rep. 2016 Sep;18(10):31
pubmed: 27614893
Blood Adv. 2018 Aug 14;2(15):1935-1945
pubmed: 30093531
Biochem J. 1988 Dec 1;256(2):357-61
pubmed: 3223916
Clin Sci (Lond). 2019 Aug 7;133(15):1745-1758
pubmed: 31358595
Neurosci Lett. 2012 Oct 18;528(1):6-10
pubmed: 22985512
Cell Rep. 2018 Oct 16;25(3):537-543.e3
pubmed: 30332635
Clin Microbiol Rev. 2010 Oct;23(4):858-83
pubmed: 20930076
J Med Microbiol. 2016 Sep;65(9):885-896
pubmed: 27381464
Annu Rev Pharmacol Toxicol. 2014;54:71-94
pubmed: 24050701
Parasitol Res. 2015 Dec;114(12):4431-9
pubmed: 26329128
Anticancer Res. 2017 Nov;37(11):5983-5993
pubmed: 29061777
Clin Infect Dis. 2018 Feb 1;66(4):548-553
pubmed: 29401275
Bioinformatics. 2016 Sep 15;32(18):2866-8
pubmed: 27153664
Infect Genet Evol. 2011 Oct;11(7):1520-8
pubmed: 21843657
Clin Infect Dis. 2012 Mar;54(6):805-9
pubmed: 22238170
J Inherit Metab Dis. 2008 Apr;31(2):205-16
pubmed: 18392741
J Infect Dis. 2019 Mar 15;219(7):1095-1103
pubmed: 30358879
Int J Parasitol Drugs Drug Resist. 2019 Dec;11:80-94
pubmed: 31707263